Following positive Phase IIa results for oral Rentosertib in GENESIS-IPF with good tolerability, a favorable PK profile, and dose-dependent efficacy improvements, the inhalation solution has received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results